ctrl K

AI Score

Unlock

Entrada Therapeutics Inc. (TRDA)

AI Score

Unlock

11.66

-0.28 (-2.35%)

At close: Mar 03, 2025, 12:32 PM

Entrada Therapeutics Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	210.78M	129.01M	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	99.88M	1.9M	1.12M	326K	104K
Gross Profit	210.78M	29.13M	-1.9M	-1.12M	-326K	-104K
Operating Income	47.01M	-3.16M	-97.25M	-51.13M	-26.67M	-11.82M
Interest Income	19.47M	15.22M	2.63M	n/a	144K	451K
Pretax Income	66.48M	12.06M	-94.62M	-51.16M	-26.52M	-5.1M
Net Income	65.63M	-6.68M	-87.46M	-50.07M	-26.38M	-4.65M
Selling & General & Admin	38.47M	32.29M	30.64M	15.2M	5.57M	3.61M
Research & Development	125.31M	99.88M	66.61M	35.93M	21.1M	8.22M
Other Expenses	n/a	n/a	n/a	n/a	n/a	6.27M
Operating Expenses	163.77M	132.18M	97.25M	51.13M	26.67M	11.82M
Interest Expense	n/a	n/a	2.63M	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	163.77M	132.18M	97.25M	51.13M	26.67M	11.82M
Income Tax	859K	18.74M	-7.16M	-1.09M	-144K	-451K
Shares Outstanding (Basic)	37.31M	33.05M	31.29M	31.22M	31.25M	31.25M
Shares Outstanding (Diluted)	39M	33.05M	31.29M	31.22M	31.25M	31.25M
EPS (Basic)	1.76	-0.2	-2.79	-1.6	-0.84	-0.15
EPS (Diluted)	1.68	-0.2	-2.79	-1.6	-0.84	-0.15
EBITDA	47.01M	-321K	-95.35M	-50.01M	-26.34M	-11.72M
Depreciation & Amortization	n/a	2.84M	1.9M	1.12M	326K	104K